PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing

Nature Immunology

Volumn 5, Issue 3, 2004, Pages 299-308

  Gyory, Ildikó ^a,b   Wu, Jian ^a,c   Fejér, György ^a,b,c   Seto, Edward ^a   Wright, Kenneth L ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BETA INTERFERON; DNA BINDING PROTEIN; HISTONE H3; HISTONE LYSINE METHYLTRANSFERASE; POSITIVE REGULATORY DOMAIN I BINDING FACTOR 1; PROTEIN BLIMP 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HISTONE METHYLTRANSFERASE; METHYLTRANSFERASE; PRDM1 PROTEIN, HUMAN; PRDM1 PROTEIN, MOUSE; REPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CATALYSIS; CHROMATIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MECHANISM; EUCHROMATIN; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MAMMAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN TARGETING; TRANSCRIPTION REGULATION; TUMOR CELL LINE; VIRUS INFECTION; AMINO ACID SEQUENCE; ENZYME SPECIFICITY; GENETIC TRANSCRIPTION; GENETICS; MACROMOLECULE; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CHROMATIN; GENE SILENCING; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; INTERFERON-BETA; MACROMOLECULAR SUBSTANCES; METHYLTRANSFERASES; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; REPRESSOR PROTEINS; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 1542347557     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1046     Document Type: Article

References (52)

1. Keller, A.D. & Maniatis, T. Identification and characterization of a novel repressor of β-interferon gene expression. Genes Dev. 5, 868-879 (1991).
2. Keller, A.D. & Maniatis, T. Only two of the five zinc fingers of the eukaryotic transcriptional repressor PRDI-BF1 are required for sequence-specific DNA binding. Mol. Cell. Biol. 12, 1940-1949 (1992).
3. Calame, K.L., Lin, K.I. & Tunyaplin, C. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21, 205-230 (2003).
4. Angelin-Duclos, C., Cattoretti, G., Lin, K.I. & Calame, K. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J. Immunol. 165, 5462-5471 (2000).
5. Turner, C.A., Jr., Mack, D.H. & Davis, M.M. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77, 297-306 (1994).
6. Messika, E.J. et al. Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J. Exp. Med. 188, 515-525 (1998).
7. Lin, Y., Wong, K. & Calame, K. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 276, 596-599 (1997).
8. Shapiro-Shelef, M. et al. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19, 607-620 (2003).
9. Shaffer, A.L. et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17, 51-62 (2002).
10. Lin, K., Angelin-Duclos, C., Kuo, T.C. & Calame, K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell. Biol. 22, 4771-4780 (2002).
11. Piskurich, J.F. et al. BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat. Immunol. 1, 526-532 (2000).
12. Ghosh, N., Gyory, I., Wright, G., Wood, J. & Wright, K.L. Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells. J. Biol. Chem. 276, 15264-15268 (2001).
13. Funabiki, T., Kreider, B.L. & Ihle, J.N. The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG. Oncogene 9, 1575-1581 (1994).
14. Xie, M., Shao, G., Buyse, I.M. & Huang, S. Transcriptional repression mediated by the PR domain zinc finger gene RIZ. J. Biol. Chem. 272, 26360-26366 (1997).
15. Abel, K.J. et al. Characterization of EZH1, a human homolog of Drosophila enhancer of zeste near BRCA1. Genomics 37, 161-171 (1996).
16. Jenuwein, T., Laible, G., Dorn, R. & Reuter, G. SET domain proteins modulate chromatin domains in eu- and heterochromatin. Cell. Mol. Life Sci. 54, 80-93 (1998).
17. Firestein, R., Cui, X., Huie, P. & Cleary, M.L. Set domain-dependent regulation of transcriptional silencing and growth control by SUV39H1, a mammalian ortholog of Drosophila Su(var)3-9. Mol. Cell. Biol. 20, 4900-4909 (2000).
18. Lachner, M. & Jenuwein, T. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14, 286-298 (2002).
19. Kouzarides, T. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12, 198-209 (2002).
20. Fears, S. et al. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proc. Natl. Acad. Sci. USA 93, 1642-1647 (1996).
21. Liu, L., Shao, G., Steele-Perkins, G. & Huang, S. The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J. Biol. Chem. 272, 2984-2991 (1997).
22. Gyory, I., Fejer, G., Ghosh, N., Seto, E. & Wright, K.L. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines. J. Immunol. 170, 3125-3133 (2003).
23. Fichelson, S. et al. Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region. Leukemia 6, 93-99 (1992).
24. He, L. et al. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res. 58, 4238-4244 (1998).
25. Jiang, G., Liu, L., Buyse, I.M., Simon, D. & Huang, S. Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int. J. Cancer 83, 541-546 (1999).
26. Ren, B., Chee, K.J., Kim, T.H. & Maniatis, T. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev. 13, 125-137 (1999).
27. Chen, G., Fernandez, J., Mische, S. & Courey, A.J. A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. Genes Dev. 13, 2218-2230 (1999).
28. Yu, J., Angelin-Duclos, C., Greenwood, J., Liao, J. & Calame, K. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol. Cell. Biol. 20, 2592-2603 (2000).
29. Tachibana, M., Sugimoto, K., Fukushima, T. & Shinkai, Y. Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J. Biol. Chem. 276, 25309-25317 (2001).
30. Rea, S. et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593-599 (2000).
31. Yang, L. et al. Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor. Oncogene 21, 148-152 (2002).
32. Schultz, D.C., Ayyanathan, K., Negorev, D., Maul, G.G. & Rauscher, F.J., 3rd. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 16, 919-932 (2002).
33. Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D.M. & Nakatani, Y.A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in GO cells. Science 296, 1132-1136 (2002).
34. Tachibana, M. et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16, 1779-1791 (2002).
35. Peters, A.H. et al. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107, 323-337 (2001).
36. Rice, J.C. et al. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol. Cell 12, 1591-1598 (2003).
37. Peters, A.H. et al. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol. Cell 12, 1577-1589 (2003).
38. Jenuwein, T. & Allis, C.D. Translating the histone code. Science 293, 1074-1080 (2001).
39. Ayyanathan, K. et al. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev. 17, 1855-1869 (2003).
40. Lomvardas, S. & Thanos, D. Modifying gene expression programs by altering core promoter chromatin architecture. Cell 110, 261-271 (2002).
41. Zhang, X. et al. Structural basis for the product specificity of histone lysine methyltransferases. Mol. Cell 12, 177-185 (2003).
42. Zhang, X. et al. Structure of the Neurospora SET domain protein DIM-5, a histone H3 lysine methyltransferase. Cell 111, 117-127 (2002).
43. Wang, H. et al. Purification and functional characterization of a histone h3-lysine 4-specific methyltransferase. Mol. Cell 8, 1207-1217 (2001).
44. Nishioka, K. et al. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev. 16, 479-489 (2002).
45. Lachner, M., O'Sullivan, R.J. & Jenuwein, T. An epigenetic road map for histone lysine methylation. J. Cell Sci. 116, 2117-2124 (2003).
46. Huang, S. Histone methyltransferases, diet nutrients and tumour suppressors. Nat. Rev. Cancer 2, 469-476 (2002).
47. Turner, B.M. Memorable transcription. Nat. Cell Biol. 5, 390-393 (2003).
48. Vandel, L. et al. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol. Cell. Biol, 21, 6484-6494 (2001).
49. Nielsen, S.J. et al. Rb targets histone H3 methylation and HP1 to promoters. Nature 412, 561-565 (2001).
50. Trimarchi, J.M. & Lees, J.A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell. Biol. 3, 11-20 (2002).
51. Oberley, M.J., Inman, D.R. & Farnham, P.J. E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9. J. Biol. Chem. 278, 42466-42476 (2003).
52. Yang, W.M., Tsai, S.C., Wen, Y.D., Fejer, G. & Seto, E. Functional domains of histone deacetylase-3. J. Biol. Chem. 277, 9447-9454 (2002).